Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Fixed time deposit | 33.32%68.58B | 37.33%60.67B | 5.16%51.44B | -33.69%44.18B | -31.23%48.91B | -7.49%66.62B | 27.14%71.13B | 21.38%72.02B | -0.61%55.94B | 8.74%59.34B |
| Reserve deposits | 7.72%6.34B | 4.96%6.43B | -2.08%5.88B | 0.22%6.13B | -1.33%6.01B | 10.28%6.11B | 5.53%6.09B | -12.25%5.54B | -0.65%5.77B | 18.04%6.32B |
| Cash and equivalents | -10.26%42.08B | 4.31%44.39B | -17.34%46.9B | 0.19%42.55B | 12.51%56.74B | 6.32%42.47B | 0.31%50.43B | 27.60%39.95B | 62.08%50.27B | 12.54%31.31B |
| Reinsurance assets | 10.11%11.77B | -4.44%10.79B | 7.00%10.69B | 5.39%11.3B | --9.99B | --10.72B | ---- | ---- | ---- | ---- |
| Insurance and other receivables | ---- | ---- | ---- | ---- | ---- | ---- | 11.70%26.3B | 13.81%20.06B | 16.11%23.54B | 18.31%17.63B |
| Financial assets at fair value through profit or loss | 0.15%444.36B | -2.28%449.97B | -0.48%443.71B | 31.18%460.49B | --445.86B | --351.03B | ---- | ---- | ---- | ---- |
| Buying back the sale of financial assets | -45.66%3.3B | -71.78%2.01B | -39.67%6.07B | -50.15%7.11B | 117.86%10.06B | 105.94%14.26B | 3.02%4.62B | 42.42%6.92B | -29.56%4.48B | -19.31%4.86B |
| Investment in joint ventures and joint ventures | -21.28%26.16B | 3.74%28.92B | 8.76%33.24B | 3.63%27.87B | 60.30%30.56B | 30.07%26.9B | -1.24%19.06B | 11.61%20.68B | 14.45%19.3B | 14.22%18.53B |
| Investment property | 0.75%24.3B | -7.52%22.83B | -0.74%24.12B | 13.08%24.69B | 5.64%24.3B | -2.71%21.83B | 4.45%23B | 19.41%22.44B | 22.48%22.02B | -1.19%18.79B |
| Property plant and equipment | 19.31%40.63B | 14.61%39.87B | 5.31%34.05B | 2.07%34.79B | 2.36%32.34B | 3.46%34.08B | 5.56%31.59B | 43.10%32.94B | 46.86%29.93B | 14.39%23.02B |
| Deferred tax assets | 49.40%9.8B | -26.45%8.5B | -37.97%6.56B | 47.13%11.55B | 40.17%10.58B | 42.65%7.85B | 191.00%7.55B | 145.67%5.5B | 34.55%2.59B | 36.43%2.24B |
| Special items of assets | -8.56%60.81B | -10.05%60.49B | 7.93%66.5B | 12.43%67.25B | -94.85%61.62B | -94.77%59.81B | 10.98%1.2T | 16.93%1.14T | 32.31%1.08T | 31.20%978.7B |
| Total assets | 14.25%1.87T | 14.90%1.73T | 15.28%1.64T | 14.22%1.51T | -1.37%1.42T | -4.14%1.32T | 11.06%1.44T | 17.93%1.38T | 30.12%1.3T | 27.15%1.17T |
| Liabilities | ||||||||||
| Insurance contract | 14.92%1.52T | 18.12%1.41T | 19.16%1.33T | 14.84%1.2T | 18.81%1.11T | 17.36%1.04T | 14.58%935.95B | 25.61%887.82B | 34.89%816.88B | 32.22%706.79B |
| Investment contract | 19.96%21.11B | 237.93%20.38B | 230.89%17.6B | 10.92%6.03B | -93.60%5.32B | -93.71%5.44B | -0.66%83.12B | 12.27%86.49B | 22.57%83.67B | 37.03%77.04B |
| Reinsurance premium payable | 36.38%192.66M | -30.40%93.08M | -68.07%141.27M | -73.67%133.74M | --442.4M | --508.01M | ---- | ---- | ---- | ---- |
| Insurance accounts payable | ---- | ---- | ---- | ---- | ---- | ---- | 24.81%74.91B | 10.13%80.05B | 2.57%60.02B | 20.98%72.68B |
| Reserve for Outstanding Losses | ---- | ---- | ---- | ---- | ---- | ---- | 15.02%32.66B | 20.46%30.68B | 19.93%28.39B | 15.40%25.47B |
| Selling repo securities | 58.14%64.14B | 59.24%46.68B | -0.46%40.56B | 7.88%29.32B | -12.17%40.74B | 40.27%27.18B | -4.07%46.39B | -49.65%19.37B | 137.80%48.36B | 11.87%38.48B |
| Deferred tax liabilities | -0.66%1.94B | -4.73%1.87B | 4.31%1.95B | 0.67%1.96B | 9.09%1.87B | 7.32%1.95B | -40.41%1.71B | -67.14%1.82B | -19.08%2.88B | 50.33%5.53B |
| Current income tax liabilities | 5.61%848.15M | -45.43%577.96M | -63.05%803.13M | -22.67%1.06B | 43.90%2.17B | -6.96%1.37B | 21.96%1.51B | 12.59%1.47B | -37.62%1.24B | 27.03%1.31B |
| Special items of liabilities | 3.87%126.66B | -9.12%128.92B | -10.68%121.95B | 6.33%141.86B | -13.71%136.53B | -15.29%133.41B | 12.96%158.23B | 25.89%157.49B | 17.60%140.07B | 10.38%125.11B |
| Total liabilities | 15.23%1.74T | 17.07%1.61T | 16.09%1.51T | 13.63%1.38T | -2.65%1.3T | -4.22%1.21T | 12.95%1.33T | 20.22%1.27T | 31.13%1.18T | 27.51%1.05T |
| Total assets less total liabilities | 3.11%136.43B | -7.68%122.41B | 6.78%132.32B | 20.76%132.6B | 14.48%123.91B | -3.22%109.8B | -7.89%108.24B | -2.71%113.46B | 20.81%117.51B | 23.98%116.61B |
| Equity | ||||||||||
| Share capital | 0.00%40.77B | 0.00%40.77B | 0.00%40.77B | 0.00%40.77B | 0.00%40.77B | 0.00%40.77B | 0.00%40.77B | 0.00%40.77B | 0.00%40.77B | 0.00%40.77B |
| Other equity instruments | -0.01%15.99B | -0.01%15.99B | 0.01%15.99B | --15.99B | --15.99B | ---- | ---- | ---- | ---- | ---- |
| Reserve | -11.66%33.47B | -20.69%30.31B | -8.18%37.88B | -11.47%38.22B | -3.81%41.26B | -8.73%43.17B | -16.03%42.89B | -5.17%47.3B | 35.44%51.08B | 40.35%49.88B |
| Shareholders' equity | -4.67%90.23B | -8.33%87.07B | -3.44%94.64B | 13.16%94.98B | 17.16%98.02B | -4.69%83.94B | -8.91%83.66B | -2.85%88.07B | 17.03%91.85B | 18.79%90.65B |
| Minority interests | 22.64%46.21B | -6.06%35.34B | 45.50%37.68B | 45.46%37.62B | 5.36%25.89B | 1.85%25.86B | -4.24%24.58B | -2.22%25.39B | 36.61%25.66B | 46.29%25.97B |
| Total equity | 3.11%136.43B | -7.68%122.41B | 6.78%132.32B | 20.76%132.6B | 14.48%123.91B | -3.22%109.8B | -7.89%108.24B | -2.71%113.46B | 20.81%117.51B | 23.98%116.61B |
| Total equity and total liabilities | 14.25%1.87T | 14.90%1.73T | 15.28%1.64T | 14.22%1.51T | -1.37%1.42T | -4.14%1.32T | 11.06%1.44T | 17.93%1.38T | 30.12%1.3T | 27.15%1.17T |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | PricewaterhouseCoopers | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.